Allan S. Wagman

Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1

Ulrich Maurer, Céline Charvet, Allan S. Wagman et al. · Molecular Cell · 2006 · 866 citations · Full text

Mitochondrial Function, Biochemistry, Natural Sciences +7

Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo

David B. Ring, Kirk W. Johnson, Erik J. Henriksen et al. · Diabetes · 2003 · 546 citations · Full text

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 248 citations · Full text

2,4-Bismorpholino 6-Heterocyclic Pyrimidines, Pi3 Kinase Inhibitor, Orally Bioavailable Class +18

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor

Jérôme Ruzzin, Allan S. Wagman, Jørgen Jensen · Diabetologia · 2005 · 239 citations · Full text

Insulin Resistance, Metabolic Syndrome, Insulin Signalling +13

The Total Synthesis of (±)-Ginkgolide B

Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet et al. · Journal of the American Chemical Society · 2000 · 105 citations

Medicinal Chemistry, Ginkgolide B, Bioorganic Chemistry +13